West Bengal chief minister Mamata Banerjee on Thursday threatened to bring her anger to the streets of New Delhi and launch an agitation in the capital if the Centre didn't give in to her demand for a moratorium on debt repayment. In a rare and exclusive interview to TOI at the Writers' Buildings in Kolkata, the Trinamool Congress chief didn't once utter the words "threat" or "pullout", but her message was...
More »SEARCH RESULT
Total Matching Records found : 358
Rural purchasing power waning on inflation, rising input costs-Heena Khan
But non-farm income keeps economy afloat New Delhi, April 25: The rural growth story is slowly losing sheen because of inflation and rising input costs. In fact, rural price level is higher than urban price level. The March Consumer Price Index number for rural India stood at 116.3, while that for urban India stood at 114.6. Mr Ajay Sriram, Chairman and Senior Managing Director, DCM Sriram Consolidated Ltd, says the rural growth...
More »Wal-Mart in bribe scandal
-The Telegraph The New York Times has reported that Wal-Mart, the US-based retail giant, hushed up an internal investigation sometime after the company was told of a bribery campaign to obtain licences and facilitate rapid expansion in Mexico. Some of the alleged instances of bribery are certain to ring a bell in India where it is not too difficult to bend rules for a price. The New York Times said its “examination...
More »Question of efficacy -Leena Menghaney
The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »
